Anthony Barron is moderating an “Issue Panel” on Comprehensive Genomic Profiling (CGP).
For more information on this event, click here.
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Anthony Barron is moderating an “Issue Panel” on Comprehensive Genomic Profiling (CGP).
For more information on this event, click here.
As more pharmaceutical companies develop and launch drugs to treat rare diseases, reimbursement decisions indicate that payers are looking at a range of...
In this first article of a three-part PharmaPhorum series exploring pricing in Europe, we discuss the role disease rarity plays in reimbursement decisions...